BRCA1 and breast carcinoma: Methylation of the BRCA1 promoter, which leads to a reduced expression of BRCA1, has been reported to be present in 11 to 14% of sporadic breast cancers [37,38], where it is associated with a higher histological grade and a triple-negative phenotype [37-39].